We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Mechanism of anticancer effect of ETP-45658, a PI3K/AKT/mTOR pathway inhibitor on HT-29 Cells

    The PI3K pathway plays a crucial role in tumor cell proliferation across various cancers, including colon cancer, making it a promising treatment...

    Fatih Yulak, Ahmet Kemal Filiz, ... Mustafa Ergul in Medical Oncology
    Article 27 October 2023
  2. Anticancer activity of lycopene in HT-29 colon cancer cell line

    An inverse association between serum lycopene levels and the risk of cancers has been pointed out by many prospective and retrospective...

    Dilara Ataseven, Ayşegül Öztürk, ... Ziad Joha in Medical Oncology
    Article 24 March 2023
  3. Campylobacter concisus from chronic inflammatory bowel diseases stimulates IL-8 production in HT-29 cells

    The emerging pathogen Campylobacter concisus has been isolated from patients with gastrointestinal diseases; however, it is also present in the gut...

    Marta Emilie Yde Aagaard, Karina Frahm Kirk, ... Henrik Nielsen in Gut Pathogens
    Article Open access 13 February 2023
  4. Exploration of the aptitude to alleviate oxidative impairment and curb colorectal cancer manifestation by Nostoc calcicola in HT-29 adenocarcinoma cells

    Background

    Marine cyanobacteria have been known to contain several unique bioactive compounds which have different therapeutic potentials. The current...

    Pragati Gupta, Syed Zameer Ahmed Khader, ... Paulpandian Manickam in Future Journal of Pharmaceutical Sciences
    Article Open access 13 November 2023
  5. The potential therapeutic effect of klotho on cell viability in human colorectal adenocarcinoma HT-29 cells

    Klotho is an anti-aging, anti-inflammator, and anti-oxidative protein and has been shown to important role in tumorigenesis, proliferation, survival,...

    Ayla Eker Sariboyaci, Onur Uysal, ... Sibel Gunes in Medical Oncology
    Article 07 September 2022
  6. Design and Characterization of Silver Nanoparticles of Different Species of Curcuma in the Treatment of Cancer Using Human Colon Cancer Cell Line (HT-29)

    Background

    Cancer is a deadly disease responsible for worldwide mortality; usually, middle- and low-income countries have been more affected by cancer...

    Akanksha Jain, Parag Jain, ... Sandip Prasad Tiwari in Journal of Gastrointestinal Cancer
    Article 19 January 2022
  7. Anticancer Effect of Sargassum oligocystom Hydroalcoholic Extract Against SW742, HT-29, WiDr, and CT-26 Colorectal Cancer Cell Lines and Expression of P53 and APC Genes

    Purpose

    Colorectal cancer (CRC) is the third most common cancer in the world, with enhancing morbidity and mortality each year. Due to the drug...

    Ibrahem Rahem Jassim Al-Aadily, Suzan Ibrahim Bajilan, ... Ali H. Al-Marzoqi in Journal of Gastrointestinal Cancer
    Article 09 January 2022
  8. Tumoricidal properties of thymoquinone on human colorectal adenocarcinoma cells via the modulation of autophagy

    Colorectal cancer (CRC) is deadly anaplastic changes in the gastrointestinal tract with high-rate mortality. In recent years, the application of...

    Mohammad Saleh Moulana, Sanya Haiaty, ... Reza Rahbarghazi in BMC Complementary Medicine and Therapies
    Article Open access 26 March 2024
  9. Antitumor activity of the new tyrphostin briva against BRAFV600E-mutant colorectal carcinoma cells

    Because of a reduced sensitivity of BRAF-mutant colorectal cancers to BRAF inhibitor treatment when compared with BRAF-mutant melanoma, it is...

    Khaled Saleh, Mai Al Sakhen, ... Bernhard Biersack in Investigational New Drugs
    Article 23 October 2023
  10. Proliferation Inhibitory Activity of Quinones from Blaps rynchopetera Defense Secretion on Colorectal Tumor Cells

    Objective

    To explore the proliferation inhibitory effect of quinones from Blaps rynchopetera defense secretion on colorectal tumor cell lines.

    ...
    **ao-li Qian, Di Meng, ... Zhong-tao Ding in Chinese Journal of Integrative Medicine
    Article 18 April 2023
  11. The pathogenicity of vancomycin-resistant Enterococcus faecalis to colon cancer cells

    Background

    The aim of this study was to investigate the pathogenicity of vancomycin-resistant Enterococcus faecalis (VREs) to human colon cells in...

    Li Zhang, Mingxia Deng, ... Wei Yu in BMC Infectious Diseases
    Article Open access 20 February 2024
  12. The in vitro treatment of mesenchymal stem cells for colorectal cancer cells

    Colorectal cancer is the most common tumor of the gastrointestinal system. The conventional treatment options for colorectal cancer are troublesome...

    Figen Abatay-Sel, Ayse Erol, ... Fatma Savran-Oguz in Medical Oncology
    Article 22 February 2023
  13. In vitro siRNA-mediated GPX4 and AKT1 silencing in oxaliplatin resistance cancer cells induces ferroptosis and apoptosis

    Oxaliplatin is a member of platinum-based chemotherapy drugs frequently used in colorectal cancer (CRC). However, resistance to oxaliplatin causes...

    Morteza Golbashirzadeh, Hamid Reza Heidari, ... Ahmad Yari Khosroushahi in Medical Oncology
    Article 26 August 2023
  14. N-methyl-D-aspartate receptors and thymoquinone induce apoptosis and alteration in mitochondria in colorectal cancer cells

    Colon cancer is on the rise in both men and women. In addition to traditional treatment methods, herbal treatments from complementary and alternative...

    Ferhat Sirinyildiz, Simge Unay in Medical Oncology
    Article 23 April 2024
  15. Evaluation of the Anti-cancer Effect of Syzygium cumini Ethanolic Extract on HT-29 Colorectal Cell Line

    Introduction

    GLOBOCAN 2018 data indicates the incidence and mortality of colorectal cancer that is the third lethal and fourth most diagnosed cancer...

    Amir Khodavirdipour, Rana Zarean, Reza Safaralizadeh in Journal of Gastrointestinal Cancer
    Article 06 June 2020
  16. Radiosensitizing effects of trabectedin on human A549 lung cancer cells and HT-29 colon cancer cells

    Background and Purpose Trabectedin is a unique alkylating agent with promising effects against a range of solid tumors. In this study, we aimed to...

    Katrin Manda, Tina Präkelt, ... Guido Hildebrandt in Investigational New Drugs
    Article 03 September 2019
  17. Combination of resveratrol and BIBR1532 inhibits proliferation of colon cancer cells by repressing expression of LncRNAs

    Colorectal cancer (CRC) is the third most common cancer worldwide. The development of tumor drug resistance is observed in the treatment of CRC....

    Selin Cesmeli, Bakiye Goker Bagca, ... Cigir Biray Avci in Medical Oncology
    Article 15 November 2021
  18. Enterotoxigenic Bacteroides fragilis activates IL-8 expression through Stat3 in colorectal cancer cells

    Background

    Enterotoxigenic Bacteroides fragilis (ETBF) has been implicated in colorectal carcinogenesis through the actions of its toxin, B. fragilis ...

    Rachel V. Purcell, Jessica Permain, Jacqueline I. Keenan in Gut Pathogens
    Article Open access 25 April 2022
  19. Anticancer properties of red beetroot hydro-alcoholic extract and its main constituent; betanin on colorectal cancer cell lines

    Colorectal cancer (CRC) is the third most common type of cancer worldwide. Red beetroot ( Beta vulgaris ) contains Betanin as its major betacyanin,...

    Amir Saber, Nasim Abedimanesh, ... Shima Moradi in BMC Complementary Medicine and Therapies
    Article Open access 18 July 2023
  20. An effective treatment approach of liposomally encapsulated metformin in colon cancer

    Metformin is a drug that is widely used in the treatment of type-2 diabetes and its anticarcinogenic effect has been detected in many studies since...

    Enis Cetin, Olcay Boyacioglu, Seda Orenay-Boyacioglu in Medical Oncology
    Article 28 February 2024
Did you find what you were looking for? Share feedback.